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Introduction
Opioids are powerful centrally acting analgesic agents,
used widely as a part of balanced anaesthesia.  They act
to smoothen the intraoperative course and decrease the
requirement of other anaesthetic agents as well as to
minimize post operative pain with minimum side effects
(1). Butorphanol is mixed agonist – antagonist(1-5) opioid
where as tramadol is an agonist at mu opioid receptors.
The purpose of this study was to compare the analgesic
efficacy and side effects of equipotent moderate doses
of tramadol & butorphanol.
Material and Methods
After approval from departmental ethics committee
and written informed consent from the patient, a
randomized study was conducted on 50 adult patients
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Abstract
The objective of the present study was to compare the analgesic efficacy and side effects of butorphanol
and tramadol.Equianalgesic doses of butorphanol (1mg) and tramadol (1mg/Kg) were compared in 50
adult patients (ASA-I) undergoing any kind of surgery requiring general anesthesia.  The patients were
divided into two groups of 25 each (n = 25).  One of the study drugs (butorphanol/tramadol) was given
intravenously just prior to induction of anesthesia in a double blind fashion. Following induction with standard
doses of propofol/thiopentone Na and succinyl choline  and  intubation, anaesthesia was maintained with
N2O/O2/Halothane.  Heart rate and blood pressure were recorded from preoperative to post operative
period in the recovery room and the frequency of side effects was noted by the trained nursing staff on
duty following direct questioning of the patients. The proportion of patients with moderate to severe pain
during postoperative period was significantly higher in tramadol group as compared to butorphanol group
(p< 0.05). Time to first rescue analgesic was significantly prolonged in butorphanol group compared to
tramadol group. The incidence of side effects was comparable in both the groups.To conclude according
to our study, butorphanol is a very effective analgesic and contributes to balanced anaesthesia.
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(ASA I), planned for elective surgery under general
anaesthesia.  The patients were divided into two groups
of 25 each.  All patients were premedicated with standard
doses of tablet diazepam and Injection glycopyrrolate.
Two minutes before induction of anaesthesia equianalgesic
doses of butorphanol(1 mg) or tramadol (1mg/Kg) were
given to the patients intravenously in a double blind fashion.
Induction of anaesthesia was done with either STP(5
mg/Kg) or propofol (2 mg/Kg) I/V followed  by
succinylcholine (2 mg/Kg) followed by tracheal
intubation.  Anaesthesia was maintained with 60% nitrous
oxide in oxygen & halothane (titrated doses) and muscle
relaxant neuromuscular blockade was reversed with
neostigmine (0.04 mg/Kg) & atropine (0.02 mg/Kg) I/V.JK SCIENCE
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Ventilation was mechanically controlled through out the
procedure.  Arterial blood pressure (non-invasive), heart
rate (non-invasive) & O2 saturation via pulse oximetery
were measured before during & after anaesthesia at an
interval of 5-10 minutes until stable in the recovery room.
The frequency of side effects e.g. nausea, vomiting,
sedation, respiratory depression, recall of events during
surgery were noted by the trained nursing staff  in the
recovery room.  Nausea & vomiting were graded
according to four point scale 3 as 0-3. O is no  N/V, 1  -
nausea only, 2 - vomiting once in last hour & 3-vomiting
more than once in last hour.  Sedation score 2,6 was
graded from 0-4. Grade 0 is no drowsiness, grade 1 is
response to speech, grade 2 is response to touch, grade 3
is response to painful stimulus and grade 4 is
unresponsiveness.  Pain was also graded from 0-3 where
grade 0 is comfortable, grade 1 is slight pain, grade 2 is
moderate pain and grade 3 is equal to severe pain
.Respiratory depression was noted from the pulse
oximetery.Rescue analgesia was provided with standard
doses of diclofenac intramuscularly to those with grade
2 or 3 pain. The data was analysed using Anova ”t” test.
p value < 0.05 was taken significant.
Results
The two groups were comparable with respect to age,
weight and sex of the patients (Table-I).   There was no
pressor response seen after intubation in patients who
received butorphanol where as pressor response was not
attenuated in tramadol group (Table-II).  The time to first
rescue analgesic was significantly higher in butorphanol
group than tramadol group.  There were more number of
patients who complained of moderate to severe pain in
tramadol group than butorphanol group (Table-III).  Post
operative side effects were elicited by direct questioning
of the patients (Table-IV). Incidence of nausea and
Table –I  Base Line Characterstics
                                      Group-I                        Group-II
Mean weight (Kg)         56.25     56.96
Age (Year)                      52.4     51.6
Male:Female                  14: 11     13 : 12
     Table –II   Haemodynamic Changes After Intubation
                     Butorphanol      Tramadol                    P Value
 HR                 80 + 5  100 + 30                     < 0.05
 SBP               130 + 5 150 + 20                       < 0.05
 DBP               80 + 5 100 + 30                       < 0.05
Table –III Time to First Rescue Analgesic( TFRA) and
 Intensity of Pain
                               Butorphanol          Tramadol             P Value
 TFRA(Min)               180 + 40              150 + 30              < 0.05
 Moderate–                  4  (16%)             14 (56%)            < 0.05
 Severe pain
  Table –IV Incidence of Post Operative Side Sffects
                          Butorphanol          Tramadol           P Value
N/V4                           (16%)                      3 (12%)      > 0.05
Sedation10                 (40%)                    4 (16%)       < 0.05
Recall of events
during surgery               Nil                       1(4%)        < 0.05
Respiratorydepression  NiL                       Nil
vomiting was higher in butorphanol group than in tramadol
group but it was statistically insignificant. Sedation (Group
3 & 4) was seen more in butorphanol group than tramadol
group (about 10 patients of butorphanol group and 4
patients of tramadol group). There is a histogram
summarizing various observations.
Discussion
The basic difference between the two drugs is their
characteristics to bind different opioid receptors of activate
the same opioid receptor in a different way.  Butorphanol
is a mixed agonist antagonist (1,6). Butorphanol is a kappa
receptor agonist as well as weak mu-receptor antagonist
(1). Because of its antagonist action on mu receptors
which are involved in supraspinal analgesia; it results in a
low incidence of respiratory depression. Butorphanol has
a ceiling effect on respiratory depression, again mediated
by mu receptors.  It is also a Kappa receptor agonist
where as tramadol has a weak affinity on mu receptors
as an agonist.  It also enhances spinal pain inhibiting
pathways by inhibiting neuronal uptake of serotonin.
In this study, we used equipotent moderate doses of each
drug used routinely by most of anesthesiologists.Patients
in butorphanol group demonstrated better protection
against autonomic stimulation to tracheal intubation asJK SCIENCE
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these patients were haemodynamically more stable
through out the operation.  This is consistent with previous
reports by Pandit et al (6) & Philip et al (7) .Butorphanol
leads to more sedation due to its action on kappa receptors
(1), where as incidence of sedation is less in tramadol
group. This property of sedation & efficient analgesia
provided by butorphanol has been used in some minor
out patient surgical procedure like oral surgery (8,9).
The rescue analgesia required in butorphanol
group was far less than tramadol group because of longer
duration of action.The enhancing action of tramadol on
serotinin often contribute to occurence of emesis (10).
The incidence of nausea and vomiting was not as high
with butrophanol as reported by Pandit et al
(6).Butorphanol does not increase the incidence of
postoperative nausea and vomiting (9). Respiratory
depression was not seen in any of the patients in both the
groups.Neither patient in butorphanol group had any recall
of procedure (11). Our study suggests that butorphanol
is a better choice than tramadol for use in balanced
anaesthesic technique because of it ability to produce
prolonged analgesia and amnesia, stable haemodynamic
parameters and no post operative respiratory depression.
Also butorphanol is effective for relieving postanesthesia
shivering without producing any significant respiratory
depression, nausia, vomiting or reccurrence of shivering
(12-14).Moreover, butorphanol as the advantage of being
non-narcotic and having a low propensity for addiction
(5,15,16).Becuse o its potent analgesic effects, alternative
routes of butorphanol have come up like caudal epidural
(17), nasal (18) and aslo in labour analgesia (19).
Conclusion
 Butorphanol is very effective and contributes to
balanced anaesthesia.
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